文献
J-GLOBAL ID:201802240258503988
整理番号:18A0279371
dupilumabと付随する局所コルチコステロイド(LIBERTY AD CHRONOS)を用いた中等度から重度のアトピー性皮膚炎の長期管理:1年間の無作為化,二重盲検,プラセボ対照,第3相試験【Powered by NICT】
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
著者 (31件):
Blauvelt Andrew
(Oregon Medical Research Center, Portland, OR, USA)
,
de Bruin-Weller Marjolein
(University Medical Center Utrecht, Utrecht, Netherlands)
,
Gooderham Melinda
(SKiN Centre for Dermatology, Queen’s University, and Probity Medical Research, Peterborough, ON, Canada)
,
Cather Jennifer C
(Modern Dermatology and Modern Research Associates, and Probity Medical Research, Dallas, TX, USA)
,
Weisman Jamie
(Advanced Medical Research, PC, Atlanta, GA, USA)
,
Pariser David
(Eastern Virginia Medical School and Virginia Clinical Research Inc, Norfolk, VA, USA)
,
Simpson Eric L
(Oregon Health and Science University, Portland, OR, USA)
,
Papp Kim A
(K Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada)
,
Hong H Chih-Ho
(Department of Dermatology and Skin Science, University of British Columbia, and Probity Medical Research, Surrey, BC, Canada)
,
Rubel Diana
(Australian National University, Canberra, and Probity Medical Research, Phillip, ACT, Australia)
,
Foley Peter
(The University of Melbourne, Parkville, Skin & Cancer Foundation Inc, Carlton, and Probity Medical Research, Carlton, VIC, Australia)
,
Prens Errol
(Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands)
,
Griffiths Christopher E M
(The Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK)
,
Etoh Takafumi
(Tokyo Teishin Postal Services Agency Hospital, Tokyo, Japan)
,
Pinto Pedro Herranz
(Department of Dermatology, La Paz University Hospital, Madrid, Spain)
,
Pujol Ramon M
(Department of Dermatology, Hospital del Mar, Barcelona, Spain)
,
Szepietowski Jacek C
(Department of Dermatology, Venereology and Allergology, Wroclaw, Poland)
,
Ettler Karel
(Dermatology and Venereology, Hradec Kralove, Czech Republic)
,
Kemeny Lajos
(Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary)
,
Zhu Xiaoping
(Regeneron Pharmaceuticals Inc, Basking Ridge, NJ, USA)
,
Akinlade Bolanle
(Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA)
,
Hultsch Thomas
(Sanofi, Cambridge, MA, USA)
,
Mastey Vera
(Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA)
,
Gadkari Abhijit
(Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA)
,
Eckert Laurent
(Sanofi, Chilly-Mazarin, France)
,
Amin Nikhil
(Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA)
,
Graham Neil M H
(Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA)
,
Pirozzi Gianluca
(Sanofi, Bridgewater, NJ, USA)
,
Stahl Neil
(Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA)
,
Yancopoulos George D
(Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA)
,
Shumel Brad
(Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA)
資料名:
Lancet
(Lancet)
巻:
389
号:
10086
ページ:
2287-2303
発行年:
2017年
JST資料番号:
B0673A
ISSN:
0140-6736
CODEN:
LANCA
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)